SLC1A5 and colorectal carcinoma: ASCT2 overexpression has also been reported in several cancers, including breast, lung cancer and hepatocellular carcinoma, and its expression levels were also associated with tumor depth and the vascular invasion in KRAS-mutant CRC [27,28,29,30,31].